The OptoSeq 3′ mRNA Library Kit allows users of Berkeley Lights’ platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system. EMERYVILLE, Calif.— Today, Berkeley Lights, a leader in cell selection, announced their new OptoSeq 3′ mRNA Library Kit enabling users to […]
– Developed in collaboration with Janssen, the Single Cell resource is being made available on the nferX® platform for free to academic researchers worldwide – – Announcement follows nference joining the COVID-19 Healthcare Coalition, a private sector collaborative with Mayo Clinic, MIT Faculty and Health IT leaders, coordinated by MITRE – nference today announced the launch of a first-in-class software […]
Company to pursue co-development collaborations for diverse clinical, pharmaceutical and biological research applications 1CellBio Inc. announced today an early access program for new droplet-based targeted cell selection and sequencing capabilities. This new approach integrates with the current inDrop workflow for a diverse range of clinical, pharmaceutical and biological research applications. The same targeted cell selection […]
In collaboration with Vanderbilt University Medical Center, La Jolla Institute for Immunology and Emory University, viral neutralization workflows on the Berkeley Lights platform are under accelerated development in response to the Coronavirus outbreak EMERYVILLE, Calif., March 26, 2020 /PRNewswire/ — Today Berkeley Lights, Inc., announced the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) with founding members Dr. James Crowe and […]
SHANGHAI, China,– Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus […]
Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 – Proteona Pte. Ltd. and partners […]
DUBLIN and TAMPA, Florida, — Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products. The companies will collaborate on the delivery of Vycellix’s novel RNA immunomodulator VY-M using Avectas’ […]
CELLvo™ Matrix Plus is a novel extracellular matrix derived from human cells that improves relevancy of cell culture studies The new cell culture substrate from StemBioSys supports isolation and culture of various cell types, including pluripotent cells. SAN ANTONIO, TX, March 24, 2020 – CELLvo™ Matrix Plus, a new extracellular matrix product from StemBioSys, Inc., […]
Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass. — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and […]
Company Builds Leadership Team for Next Stage of Growth with Expanded Commercialization of Organs-on-Chips Product Suite BOSTON, Mass. – March 19, 2020 – Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s Board of Directors. These life science […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
